What is COVID-19?
COVID-19 is the disease caused by the virus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 is a new strain of coronavirus. It had not been identified in humans before December 2019.
There are many different types of coronavirus. Coronaviruses mostly infect animals, but some can also infect humans.
The current COVID-19 outbreak started in late 2019; the World Health Organization (WHO) declared it a pandemic on 11 March 2020 .
This is the first pandemic caused by a coronavirus.
What are the symptoms of COVID-19?
The main symptoms of COVID-19 are:
- general weakness or fatigue
- a change in or loss of taste or smell
- sore throat
- muscle pains
The severity of the disease varies widely from person to person.
Some people with COVID-19 are asymptomatic. This means that they have no symptoms at all.
In serious cases, symptoms can include
- difficulty breathing or shortness of breath
- chest pain.
People with severe symptoms may need specialised medical care and support.
A patient’s condition can quickly worsen and if so, this will often occur the second week of disease.
Unfortunately, some people with COVID-19 need to go into hospital. Some of them may even require intensive care, occasionally for extended periods.
What are the complications of COVID-19?
People with severe symptoms affecting the airways may need to go on a respirator (mechanical ventilation support). This can make them more susceptible to catching an infection on top of COVID-19, such as pneumonia.
Some COVID-19 patients are also at higher risk of complications related to blood clotting, such as strokes or heart attacks.
In addition, patients can sometimes experience symptoms related to the nervous system. These can include temporary personality changes or altered levels of alertness.
The likelihood of needing to go into hospital is higher for older people, in particular people over 60 years and those with underlying health conditions.
In general, the risk of dying from COVID-19 is low, but higher than it is for flu. The risk of dying is higher in older people, as well as in people who have long-term illnesses or underlying conditions..
What is long-term COVID-19?
A small number of patients may suffer long-term effects from COVID-19 infection. This is called post-COVID-19 condition or long-term COVID-19.
Long-term COVID-19 affects patients of all ages, including people who only had mild COVID-19 symptoms when first infected.
- general weakness
- loss of smell
- nerve pain
- sleep disorders
Full recovery can take up to six months. There is currently no treatment for this condition.
How does COVID-19 spread?
The SARS-CoV-2 virus spreads from person to person primarily via tiny particles released into the air when an infected person breathes, particularly when speaking, singing, shouting, sneezing, coughing, etc.. These particles can then reach other people close by (usually up to two metres away), who can breathe them in.
Larger particles (droplets) can also land on surfaces that other people touch. These people may then pick the virus up on their hands and become infected when they touch their nose, mouth or eyes. The virus can survive for several hours on surfaces such as copper or cardboard, and on plastic and stainless steel surfaces it can survive for a few days.
Transmission from one infected person to another can start two days before the infected person even begins to show symptoms. On average, one infected person will infect up to five other people, if they do not take any measures to prevent transmission.
It usually takes five to six days for someone to start to showing symptoms after being infected. However this can vary from one day to two weeks.
Who is at risk of COVID-19?
Everyone is at risk of getting COVID-19.
However, some population groups are more likely to develop severe disease. These include people over 60 years and pregnant women, as well as people with underlying health conditions, such as:
- high blood pressure
- heart disease
- long-term diseases affecting the lungs and airways
- conditions affecting the nervous system
- a weakened immune system.
Symptoms in adults also tend to be more severe than in children. Nevertheless, children still pass the virus on to others, and some do develop severe disease.
Crowded indoor spaces provide opportunities for COVID-19 to spread quickly: prisons, migrant centres and food-processing plants have all seen significant outbreaks.
It is possible that cold or damp air can increase the chances of the virus passing from one person to another.
How can COVID-19 be prevented?
The most effective way to prevent COVID-19 is vaccination - together with measures such as wearing face masks and physical distancing. People who are vaccinated are less likely to have severe disease or to need to go into hospital. This is the why public-health bodies are urging all eligible people to get fully vaccinated against COVID-19 as soon as possible. Read more about COVID-19 vaccines.
Keeping physical distance from others, good ventilation of indoor spaces and wearing a facemask are all measures which help stop transmission.
Washing hands frequently with soap and water or using alcohol-based solutions also helps prevent the transfer of the virus from the hands into the body via the eyes, nose or mouth. For more details, see our infographic on non-pharmaceutical measures.
How is COVID-19 treated?
Medicines to treat COVID-19 that target the virus directly are becoming available. However, these are mainly used to prevent severe disease in high-risk groups.
The main treatment for most patients with severe disease is supportive care, (e.g. using oxygen therapy and managing fluid levels) which is often highly effective.
For the latest information on COVID-19 treatments, visit the European Medicines Agency’s (EMA) website: Treatments and vaccines for COVID-19 or the European Commission website: Treatments for COVID-19 (europa.eu)
- European Commission: Coronavirus response
- ECDC: The latest surveillance data: COVID-19 situation update worldwide
- ECDC: COVID-19 pandemic
- ECDC: Latest evidence on COVID-19
- ECDC: Q&A on COVID-19
- ECDC: High-risk groups for COVID-19
- ECDC: How to protect yourself and others
(1) WHO Director-General's opening remarks at the media briefing on COVID-19, 11 March 2020. Available at:https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
Note: This factsheet is intended for the purpose of general information and should not be used as a substitute for the individual expertise and judgement of a healthcare professional.
The EU is responsible for ensuring that safe and effective COVID-19 vaccines reach the public in the EU/EEA. The European Commission authorises COVID-19 vaccines, after evaluation by the European Medicines Agency (EMA) and consultation with the EU Member States. The first vaccines were given at the end of 2020.